{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:04:52Z","timestamp":1792796692874,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Young Top-notch Talent Cultivation Program of Hubei Province."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pluripotent cancer stem cells play a pivotal role in inducing phenotypic plasticity across various cancer types, including bladder cancer. This plasticity, crucial for cancer progression, is largely regulated by epigenetic modifications including N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) in RNAs. However, the role of the m\n                    <jats:sup>6<\/jats:sup>\n                    A reader protein YTHDC2 in this process remains poorly understood. In this study, we uncovered that the depletion of YTHDC2 significantly increased the pool of bladder cancer stem cells (BCSCs), resulting in a phenotypic shift towards a more invasive subtype of bladder cancer. This shift was characterized by enhanced proliferation, migration, invasion, and self-renewal capabilities of cancer cells, highlighting YTHDC2\u2019s function as a tumor suppressor. Mechanistically, YTHDC2 recognized and bound to m\n                    <jats:sup>6<\/jats:sup>\n                    A-modified\n                    <jats:italic>SOX2<\/jats:italic>\n                    mRNA, resulting in translational inhibition of SOX2. In conclusion, our study identifies YTHDC2 as a tumor suppressor in bladder cancer through inhibiting SOX2-mediated cell pluripotency and underscores the therapeutic potential of targeting the YTHDC2-SOX2 axis in bladder cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08079-w","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:14:18Z","timestamp":1761581658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity"],"prefix":"10.1038","volume":"16","author":[{"given":"Yi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Long","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Jing","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-725X","authenticated-orcid":false,"given":"Xian-Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-612X","authenticated-orcid":false,"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-5671","authenticated-orcid":false,"given":"Hong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"8079_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8079_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"8079_CR3","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.7150\/thno.41648","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10:8721\u201343.","journal-title":"Theranostics"},{"key":"8079_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21:325\u201338.","journal-title":"Nat Rev Cancer"},{"key":"8079_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctrv.2016.07.001","volume":"49","author":"A Carnero","year":"2016","unstructured":"Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME. The cancer stem-cell signaling network and resistance to therapy. Cancer Treat Rev. 2016;49:25\u201336.","journal-title":"Cancer Treat Rev"},{"key":"8079_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10555-009-9187-6","volume":"28","author":"WD Brandt","year":"2009","unstructured":"Brandt WD, Matsui W, Rosenberg JE, He X, Ling S, Schaeffer EM, et al. Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Rev. 2009;28:291\u2013304.","journal-title":"Cancer Metastasis Rev"},{"key":"8079_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2016.06.025","volume":"71","author":"Z Yang","year":"2017","unstructured":"Yang Z, Li C, Fan Z, Liu H, Zhang X, Cai Z, et al. Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. Eur Urol. 2017;71:8\u201312.","journal-title":"Eur Urol"},{"key":"8079_CR8","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1002\/jcp.26916","volume":"234","author":"N Aghaalikhani","year":"2019","unstructured":"Aghaalikhani N, Rashtchizadeh N, Shadpour P, Allameh A, Mahmoodi M. Cancer stem cells as a therapeutic target in bladder cancer. J Cell Physiol. 2019;234:3197\u2013206.","journal-title":"J Cell Physiol"},{"key":"8079_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell\u2013immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21:526\u201336.","journal-title":"Nat Rev Cancer"},{"key":"8079_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523\u201331.","journal-title":"Cell Stem Cell"},{"key":"8079_CR11","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm1744","volume":"6","author":"M Boiani","year":"2005","unstructured":"Boiani M, Sch\u00f6ler HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol cell Biol. 2005;6:872\u201384.","journal-title":"Nat Rev Mol cell Biol"},{"key":"8079_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak D, H\u00fcser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67:74\u201382.","journal-title":"Semin Cancer Biol"},{"key":"8079_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109990","volume":"37","author":"JR Valcourt","year":"2021","unstructured":"Valcourt JR, Huang RE, Kundu S, Venkatasubramanian D, Kingston RE, Ramanathan S. Modulating mesendoderm competence during human germ layer differentiation. Cell Rep. 2021;37:109990.","journal-title":"Cell Rep"},{"key":"8079_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature09729","volume":"470","author":"T Takemoto","year":"2011","unstructured":"Takemoto T, Uchikawa M, Yoshida M, Bell DM, Lovell-Badge R, Papaioannou VE, et al. Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. Nature. 2011;470:394\u20138.","journal-title":"Nature"},{"key":"8079_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/modpathol.2012.139","volume":"26","author":"H Kitamura","year":"2013","unstructured":"Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, et al. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol. 2013;26:117\u201324.","journal-title":"Mod Pathol"},{"key":"8079_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ctrv.2015.02.006","volume":"41","author":"JJ Leow","year":"2015","unstructured":"Leow JJ, Orsola A, Chang SL, Bellmunt J. A contemporary review of management and prognostic factors of upper tract urothelial carcinoma. Cancer Treat Rev. 2015;41:310\u20139.","journal-title":"Cancer Treat Rev"},{"key":"8079_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.stemcr.2017.07.004","volume":"9","author":"F Zhu","year":"2017","unstructured":"Zhu F, Qian W, Zhang H, Liang Y, Wu M, Zhang Y, et al. SOX2 is a marker for stem-like tumor cells in bladder cancer. Stem Cell Rep. 2017;9:429\u201337.","journal-title":"Stem Cell Rep"},{"key":"8079_CR18","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149:2099\u2013115.","journal-title":"Int J Cancer"},{"key":"8079_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41418-019-0377-7","volume":"27","author":"X Hua","year":"2020","unstructured":"Hua X, Huang M, Deng X, Xu J, Luo Y, Xie Q, et al. The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein. Cell Death Differ. 2020;27:632\u201345.","journal-title":"Cell Death Differ"},{"key":"8079_CR20","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1158\/0008-5472.CAN-21-0567","volume":"81","author":"X Wang","year":"2021","unstructured":"Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J, et al. Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11. Cancer Res. 2021;81:5217\u201329.","journal-title":"Cancer Res"},{"key":"8079_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2013.08.001","volume":"39","author":"M Mimeault","year":"2014","unstructured":"Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem\/progenitor cells and multitargeted therapies. Mol Asp Med. 2014;39:3\u201332.","journal-title":"Mol Asp Med"},{"key":"8079_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m(6)A in the transcriptome: m(6)A-binding proteins. Trends Cell Biol. 2018;28:113\u201327.","journal-title":"Trends Cell Biol"},{"key":"8079_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m\u2076A RNA methylation. Nat Rev Genet. 2014;15:293\u2013306.","journal-title":"Nat Rev Genet"},{"key":"8079_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27:1115\u201327.","journal-title":"Cell Res"},{"key":"8079_CR25","doi-asserted-by":"crossref","unstructured":"Bailey AS, Batista PJ, Gold RS, Chen YG, de Rooij DG, Chang HY, et al. The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline. eLife. 2017;6:e26116.","DOI":"10.7554\/eLife.26116"},{"key":"8079_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41588-023-01452-5","volume":"55","author":"T Sun","year":"2023","unstructured":"Sun T, Xu Y, Xiang Y, Ou J, Soderblom EJ, Diao Y. Crosstalk between RNA m(6)A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells. Nat Genet. 2023;55:1324\u201335.","journal-title":"Nat Genet"},{"key":"8079_CR27","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"8079_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","volume":"32","author":"CD Hurst","year":"2017","unstructured":"Hurst CD, Alder O, Platt FM, Droop A, Stead LF, Burns JE, et al. Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency. Cancer Cell. 2017;32:701\u201315.e7.","journal-title":"Cancer Cell"},{"key":"8079_CR29","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m P-U, Choi W, et al. Bladder cancer. The Lancet. 2016;388:2796\u2013810.","journal-title":"The Lancet"},{"key":"8079_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"JN Weinstein","year":"2014","unstructured":"Weinstein JN, Akbani R, Broom BM, Wang W, Verhaak RGW, McConkey D, et al. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","journal-title":"Nature"},{"key":"8079_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrg3317","volume":"13","author":"LR Yates","year":"2012","unstructured":"Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet. 2012;13:795\u2013806.","journal-title":"Nat Rev Genet"},{"key":"8079_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","volume":"76","author":"AA Hamid","year":"2019","unstructured":"Hamid AA, Gray KP, Shaw G, MacConaill LE, Evan C, Bernard B, et al. Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer. Eur Urol. 2019;76:89\u201397.","journal-title":"Eur Urol"},{"key":"8079_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","volume":"19","author":"F Skoulidis","year":"2019","unstructured":"Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19:495\u2013509.","journal-title":"Nat Rev Cancer"},{"key":"8079_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","volume":"37","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou C, Li X, Barnes SD, Deng S, Hoover E, et al. Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation. Cancer Cell. 2020;37:584\u201398.e11.","journal-title":"Cancer Cell"},{"key":"8079_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19173-2","volume":"11","author":"YH Cho","year":"2020","unstructured":"Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, et al. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT\/\u03b2-catenin pathway activation. Nat Commun. 2020;11:5321.","journal-title":"Nat Commun"},{"key":"8079_CR36","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.ymthe.2020.10.011","volume":"29","author":"Q Wu","year":"2021","unstructured":"Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. lncRNA SNHG11 promotes gastric cancer progression by activating the Wnt\/\u03b2-catenin pathway and oncogenic autophagy. Mol Ther J Am Soc Gene Ther. 2021;29:1258\u201378.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"8079_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.7150\/thno.66142","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ruan X, Li Y, Zhi J, Hu L, Hou X, et al. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt\/\u03b2-catenin signaling pathway. Theranostics. 2022;12:1500\u201317.","journal-title":"Theranostics"},{"key":"8079_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41419-022-05128-6","volume":"13","author":"T Hou","year":"2022","unstructured":"Hou T, Dan W, Liu T, Liu B, Wei Y, Yue C, et al. Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression. Cell Death Dis. 2022;13:778.","journal-title":"Cell Death Dis"},{"key":"8079_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","volume":"41","author":"M Chi","year":"2022","unstructured":"Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, et al. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer. J Exp Clin Cancer Res. 2022;41:175.","journal-title":"J Exp Clin Cancer Res"},{"key":"8079_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41419-021-03819-0","volume":"12","author":"Z Huang","year":"2021","unstructured":"Huang Z, Yan Y, Zhu Z, Liu J, He X, Dalangood S, et al. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10\u2013ERK signaling. Cell Death Dis. 2021;12:537.","journal-title":"Cell Death Dis"},{"key":"8079_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109.","journal-title":"Mol Cancer"},{"key":"8079_CR42","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42:1347\u201366.","journal-title":"Cancer Commun"},{"key":"8079_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37696-2","volume":"14","author":"M Minoli","year":"2023","unstructured":"Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F, et al. Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nat Commun. 2023;14:2214.","journal-title":"Nat Commun"},{"key":"8079_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11914","volume":"7","author":"G Papafotiou","year":"2016","unstructured":"Papafotiou G, Paraskevopoulou V, Vasilaki E, Kanaki Z, Paschalidis N, Klinakis A. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat Commun. 2016;7:11914.","journal-title":"Nat Commun"},{"key":"8079_CR45","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27:1115\u201327.","journal-title":"Cell Res"},{"key":"8079_CR46","doi-asserted-by":"crossref","unstructured":"Gilbert WV, Bell TA, Schaening C. Messenger RNA modifications: form, distribution, and function. Science. 2016;352:1408\u201312.","DOI":"10.1126\/science.aad8711"},{"key":"8079_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Sig Transduct Target Ther. 2020;5:8.","journal-title":"Sig Transduct Target Ther"},{"key":"8079_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1143-7","volume":"19","author":"Y Zhan","year":"2020","unstructured":"Zhan Y, Chen Z, He S, Gong Y, He A, Li Y, et al. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2. Mol Cancer. 2020;19:25.","journal-title":"Mol Cancer"},{"key":"8079_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41416-020-01150-7","volume":"124","author":"B Coban","year":"2021","unstructured":"Coban B, Bergonzini C, Zweemer AJM, Danen EHJ. Metastasis: crosstalk between tissue mechanics and tumour cell plasticity. Br J cancer. 2021;124:49\u201357.","journal-title":"Br J cancer"},{"key":"8079_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.950241","volume":"10","author":"J Tan","year":"2022","unstructured":"Tan J, Wang Y, Sun L, Xu S, Li C, Jin X. The origin and evolution of bladder cancer stem cells. Front cell Dev Biol. 2022;10:950241.","journal-title":"Front cell Dev Biol"},{"key":"8079_CR51","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41588-023-01568-8","volume":"55","author":"R Li","year":"2023","unstructured":"Li R, Zhao H, Huang X, Zhang J, Bai R, Zhuang L, et al. Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Nat Genet. 2023;55:2224\u201334.","journal-title":"Nat Genet"},{"key":"8079_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05293-6","volume":"22","author":"X Wu","year":"2024","unstructured":"Wu X, Chen H, Li K, Zhang H, Li K, Tan H. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases. J Transl Med. 2024;22:490.","journal-title":"J Transl Med"},{"key":"8079_CR53","doi-asserted-by":"crossref","unstructured":"Nargis N, Lind A, Sczepanski A, Herndon R, Smiley O, Somji S, et al. SOX2 regulates growth, expression of basal\/luminal markers, and chemotherapy response in urothelial carcinoma. Cells. 2025;14:949.","DOI":"10.3390\/cells14130949"},{"key":"8079_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?. Mol Cancer. 2023;22:90.","journal-title":"Mol Cancer"},{"key":"8079_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8079_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nsmb.3148","volume":"23","author":"J Choi","year":"2016","unstructured":"Choi J, Ieong K-W, Demirci H, Chen J, Petrov A, Prabhakar A, et al. N6-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics. Nat Struct Mol Biol. 2016;23:110\u20135.","journal-title":"Nat Struct Mol Biol"},{"key":"8079_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270\u201388.","journal-title":"Cancer Cell"},{"key":"8079_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8079_CR59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40:1550\u201365.e7.","journal-title":"Cancer Cell"},{"key":"8079_CR60","doi-asserted-by":"crossref","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22:2622.","DOI":"10.3390\/ijms22052622"},{"key":"8079_CR61","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gy\u0151rffy","year":"2023","unstructured":"Gy\u0151rffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. GeroScience. 2023;45:1889\u201398.","journal-title":"GeroScience"},{"key":"8079_CR62","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u2013D63.","journal-title":"Nucleic Acids Res"},{"key":"8079_CR63","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u2013w21.","journal-title":"Nucleic Acids Res"},{"key":"8079_CR64","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/molbev\/msu167","volume":"31","author":"F Cheng","year":"2014","unstructured":"Cheng F, Jia P, Wang Q, Lin CC, Li WH, Zhao Z. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol Biol Evol. 2014;31:2156\u201369.","journal-title":"Mol Biol Evol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08079-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:09:29Z","timestamp":1761908969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08079-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8079"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08079-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Experimental Animal Welfare Ethics Committee of Zhongnan Hospital of Wuhan University (Ethics number ZN2021113). We confirm that all animal care procedures and experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"765"}}